• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过透明质酸酶对透明质酸填充剂的降解性进行标准化的体外分析。

Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase.

机构信息

Departments of Dermatology, Medical Faculty, Research Laboratory for Dermatology and Immunology, Heinrich-Heine-University Duesseldorf, University Hospital Duesseldorf, Duesseldorf, Germany.

Departments of Radiation Oncology, Medical Faculty, Research Laboratory for Dermatology and Immunology, Heinrich-Heine-University Duesseldorf, University Hospital Duesseldorf, Duesseldorf, Germany.

出版信息

Eur J Med Res. 2018 Aug 20;23(1):37. doi: 10.1186/s40001-018-0334-9.

DOI:10.1186/s40001-018-0334-9
PMID:30122153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6100712/
Abstract

BACKGROUND

Hyaluronidase is a hyaluronic acid (HA) metabolizing enzyme, which is approved as an adjuvant for infiltration anesthesia. The "off-label" use of hyaluronidase is regarded as gold standard for the management of HA-filler-associated complications. Yet, up to date there are only few studies that have systematically assessed the degradability of different HA-fillers by hyaluronidase.

OBJECTIVE

To analyze the interactions of HA-fillers and hyaluronidase in a time-dependent manner using a novel standardized in vitro approach.

METHODS

Comparable HA-fillers, Belotero Balance Lidocaine (BEL; Merz), Emervel classic (EMV; Galderma) and Juvederm Ultra 3 (JUV; Allergan), were incubated with a fluorescent dye and bovine hyaluronidase (HYAL; Hylase "Dessau", Riemser) or control (NaCl) and monitored by time-lapse videomicroscopy. The degradation of HA-fillers was assessed as decrease in fluorescence intensity of HA-filler plus hyaluronidase vs. HA-filler plus control, quantified by computer-assisted image analysis (ImageJ).

RESULTS

Hyaluronidase showed a significant degradation of the HA-fillers BEL and EMV. Degradation was measurable at 5 h (BEL) and 7 h (EMV), respectively; significance was reached at 14 h (BEL) and 13 h (EMV). No effect of hyaluronidase was observed for JUV.

CONCLUSION

Time-lapse microscopy enables systematically, standardized, comparative in vitro analyses of the interactions of hyaluronidase and HA-fillers.

摘要

背景

透明质酸酶是一种透明质酸(HA)代谢酶,已被批准作为浸润麻醉的辅助剂。透明质酸酶的“超适应证”使用被视为管理 HA 填充剂相关并发症的金标准。然而,迄今为止,只有少数研究系统评估了不同 HA 填充剂的可降解性。

目的

采用新的标准化体外方法,分析透明质酸酶与 HA 填充剂的时间依赖性相互作用。

方法

采用荧光染料和牛透明质酸酶(HYAL;Hylase“Dessau”,Riemser)或对照(NaCl)孵育可比 HA 填充剂 Belotero Balance Lidocaine(BEL;Merz)、Emervel classic(EMV;Galderma)和 Juvederm Ultra 3(JUV;Allergan),并用延时视频显微镜进行监测。通过计算机辅助图像分析(ImageJ)评估 HA 填充剂的降解情况,即 HA 填充剂加透明质酸酶与 HA 填充剂加对照的荧光强度降低。

结果

透明质酸酶对 BEL 和 EMV 两种 HA 填充剂均有显著的降解作用。分别在 5 小时(BEL)和 7 小时(EMV)时可测量到降解;在 14 小时(BEL)和 13 小时(EMV)时达到显著水平。JUV 无透明质酸酶作用。

结论

延时显微镜可用于系统、标准化、比较透明质酸酶与 HA 填充剂相互作用的体外分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f9c/6100712/52d6a8a615f7/40001_2018_334_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f9c/6100712/0276588f2004/40001_2018_334_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f9c/6100712/52d6a8a615f7/40001_2018_334_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f9c/6100712/0276588f2004/40001_2018_334_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f9c/6100712/52d6a8a615f7/40001_2018_334_Fig2_HTML.jpg

相似文献

1
Standardized in vitro analysis of the degradability of hyaluronic acid fillers by hyaluronidase.通过透明质酸酶对透明质酸填充剂的降解性进行标准化的体外分析。
Eur J Med Res. 2018 Aug 20;23(1):37. doi: 10.1186/s40001-018-0334-9.
2
Time- and Dose-Dependent Effects of Hyaluronidase on the Degradation of Different Hyaluronan-Based Fillers In Vitro.透明质酸酶对不同透明质酸基填充剂体外降解的时间和剂量依赖性效应
Plast Reconstr Surg. 2023 Mar 1;151(3):560-567. doi: 10.1097/PRS.0000000000009916. Epub 2022 Nov 22.
3
Degradation of Hylauronic Acid Fillers Using Hyaluronidase in an In Vivo Model.在体内模型中使用透明质酸酶降解透明质酸填充剂
J Drugs Dermatol. 2018 May 1;17(5):548-553.
4
The Kinetics of Reversible Hyaluronic Acid Filler Injection Treated With Hyaluronidase.用透明质酸酶治疗的可逆性透明质酸填充剂注射的动力学
Dermatol Surg. 2017 Jun;43(6):841-847. doi: 10.1097/DSS.0000000000001084.
5
Comparison of Hyaluronidase-Mediated Degradation Kinetics of Commercially Available Hyaluronic Acid Fillers In Vitro.体外比较市售透明质酸填充剂的透明质酸酶介导降解动力学。
Aesthet Surg J. 2024 May 15;44(6):NP402-NP410. doi: 10.1093/asj/sjae032.
6
Response of twelve different hyaluronic acid gels to varying doses of recombinant human hyaluronidase.十二种不同透明质酸凝胶对不同剂量重组人透明质酸酶的反应。
J Plast Reconstr Aesthet Surg. 2021 Apr;74(4):881-889. doi: 10.1016/j.bjps.2020.10.051. Epub 2020 Nov 6.
7
Reversing facial fillers: interactions between hyaluronidase and commercially available hyaluronic-acid based fillers.面部填充剂的逆转:透明质酸酶与市售透明质酸基填充剂之间的相互作用
J Drugs Dermatol. 2014 Sep;13(9):1053-6.
8
Quantifying the Digestion of Cross-Linked Hyaluronic Acid Fillers With Hyaluronidase.定量分析透明质酸酶对交联透明质酸填充物的消化作用。
Dermatol Surg. 2021 Sep 1;47(9):1233-1236. doi: 10.1097/DSS.0000000000003090.
9
In Vivo Degradation of Crosslinked Hyaluronic Acid Fillers by Exogenous Hyaluronidases.外源性透明质酸酶对交联透明质酸填充剂的体内降解作用
Dermatol Surg. 2018 Aug;44(8):1075-1083. doi: 10.1097/DSS.0000000000001525.
10
Resolve and dissolve-An ultrasound-guided investigation on the effects of hyaluronidase on different soft tissue fillers.解决与溶解——透明质酸酶对不同软组织填充剂作用的超声引导研究。
J Cosmet Dermatol. 2024 Oct;23(10):3173-3181. doi: 10.1111/jocd.16393. Epub 2024 May 20.

引用本文的文献

1
A Review: Causes, Consequences, and Management Strategies of Facial Overfilling.综述:面部过度填充的原因、后果及管理策略
Clin Cosmet Investig Dermatol. 2025 Aug 4;18:1857-1864. doi: 10.2147/CCID.S539888. eCollection 2025.
2
Guide for Managing Vascular Occlusion Caused by Fillers with Exclusive Cutaneous Involvement: A Review of Diagnosis, Classification, and Treatment.仅累及皮肤的填充剂所致血管闭塞的管理指南:诊断、分类及治疗综述
Aesthetic Plast Surg. 2025 Aug 6. doi: 10.1007/s00266-025-05104-3.
3
Rheology as a Tool to Investigate the Degradability of Hyaluronic Acid Dermal Fillers.

本文引用的文献

1
A Trickster in Disguise: Hyaluronan's Ambivalent Roles in the Matrix.伪装的骗子:透明质酸在细胞外基质中的矛盾作用
Front Oncol. 2017 Oct 9;7:242. doi: 10.3389/fonc.2017.00242. eCollection 2017.
2
The Kinetics of Reversible Hyaluronic Acid Filler Injection Treated With Hyaluronidase.用透明质酸酶治疗的可逆性透明质酸填充剂注射的动力学
Dermatol Surg. 2017 Jun;43(6):841-847. doi: 10.1097/DSS.0000000000001084.
3
Quantitative Correlation Between Hyaluronic Acid Filler and Hyaluronidase.透明质酸填充剂与透明质酸酶之间的定量相关性
流变学作为研究透明质酸真皮填充剂降解性的工具
Clin Cosmet Investig Dermatol. 2025 May 31;18:1349-1358. doi: 10.2147/CCID.S519217. eCollection 2025.
4
Hyaluronic Acid and Skin: Its Role in Aging and Wound-Healing Processes.透明质酸与皮肤:其在衰老和伤口愈合过程中的作用
Gels. 2025 Apr 9;11(4):281. doi: 10.3390/gels11040281.
5
Retrobulbar Hyaluronidase in Hyaluronic Acid-Induced Ocular Vascular Occlusion: Efficacy, Challenges, and Implications for Clinical Practice.球后透明质酸酶在透明质酸诱导的眼部血管阻塞中的应用:疗效、挑战及对临床实践的启示
Aesthetic Plast Surg. 2025 Mar;49(5):1458-1468. doi: 10.1007/s00266-024-04483-3. Epub 2024 Oct 28.
6
Dual Functionalization of Hyaluronan Dermal Fillers with Vitamin B3: Efficient Combination of Bio-Stimulation Properties with Hydrogel System Resilience Enhancement.用维生素B3对透明质酸真皮填充剂进行双重功能化:生物刺激特性与水凝胶系统弹性增强的有效结合。
Gels. 2024 May 24;10(6):361. doi: 10.3390/gels10060361.
7
High-dose pulsed hyaluronidase for managing nasal skin necrosis following hyaluronic acid treatment in nasolabial folds: A case report.大剂量脉冲式透明质酸酶治疗鼻唇沟玻尿酸填充后鼻皮肤坏死1例报告
J Oral Biol Craniofac Res. 2024 May-Jun;14(3):339-341. doi: 10.1016/j.jobcr.2024.04.006. Epub 2024 Apr 22.
8
Comparison of Hyaluronidase-Mediated Degradation Kinetics of Commercially Available Hyaluronic Acid Fillers In Vitro.体外比较市售透明质酸填充剂的透明质酸酶介导降解动力学。
Aesthet Surg J. 2024 May 15;44(6):NP402-NP410. doi: 10.1093/asj/sjae032.
9
Determination of Hyaluronic Acid Dermal Filler Impurities Using SEM/EDS Analysis.使用扫描电子显微镜/能谱分析(SEM/EDS)测定透明质酸真皮填充剂中的杂质
Polymers (Basel). 2023 Mar 26;15(7):1649. doi: 10.3390/polym15071649.
10
A Safe-by-Design Approach for the Synthesis of a Novel Cross-Linked Hyaluronic Acid with Improved Biological and Physical Properties.一种通过设计确保安全的方法来合成具有改善的生物学和物理性质的新型交联透明质酸。
Pharmaceuticals (Basel). 2023 Mar 11;16(3):431. doi: 10.3390/ph16030431.
J Craniofac Surg. 2017 May;28(3):838-841. doi: 10.1097/SCS.0000000000003411.
4
Comparison of Intra-arterial and Subcutaneous Testicular Hyaluronidase Injection Treatments and the Vascular Complications of Hyaluronic Acid Filler.动脉内注射与皮下注射睾丸透明质酸酶治疗及透明质酸填充剂血管并发症的比较
Dermatol Surg. 2017 Feb;43(2):246-254. doi: 10.1097/DSS.0000000000000955.
5
Injected Hyaluronidase Reduces the Volume of Exogenous Hyaluronate Fillers in Mice and Results in Clinical Improvement in a Patient with Pretibial Myxedema.注射透明质酸酶可减少小鼠体内外源性透明质酸填充剂的体积,并使一名胫前黏液性水肿患者的临床症状得到改善。
Dermatopathology (Basel). 2016 Jul 6;3(3):61-7. doi: 10.1159/000446699. eCollection 2016 Jul-Sep.
6
Hyaluronidase: from clinical applications to molecular and cellular mechanisms.透明质酸酶:从临床应用到分子与细胞机制
Eur J Med Res. 2016 Feb 13;21:5. doi: 10.1186/s40001-016-0201-5.
7
Reversing facial fillers: interactions between hyaluronidase and commercially available hyaluronic-acid based fillers.面部填充剂的逆转:透明质酸酶与市售透明质酸基填充剂之间的相互作用
J Drugs Dermatol. 2014 Sep;13(9):1053-6.
8
[Management of complications after aesthetic hyaluronic acid injections].[透明质酸美容注射后并发症的处理]
Hautarzt. 2014 Oct;65(10):851-3. doi: 10.1007/s00105-014-3511-y.
9
Hyaluronidase injection for the treatment of eyelid edema: a retrospective analysis of 20 patients.透明质酸酶注射治疗眼睑水肿:20 例患者的回顾性分析。
Eur J Med Res. 2014 May 28;19(1):30. doi: 10.1186/2047-783X-19-30.
10
Hyaluronic acid: A key molecule in skin aging.透明质酸:皮肤衰老中的关键分子。
Dermatoendocrinol. 2012 Jul 1;4(3):253-8. doi: 10.4161/derm.21923.